30 Apr 2020
Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services Enter into a Development Collaboration for a Novel Antibody Therapeutic
Author: admintech | Filed under: Press ReleaseSAN DIEGO and SAN FRANCISCO, April 30, 2020 /PRNewswire/ — Trio Pharmaceuticals, Inc. (“TRIO”), a cancer therapeutics company developing novel dual action antibody drugs, TRIObody™, and novel dual action antibody drug conjugates, TRIObody Drug Conjugate™ (TDC™) and Ajinomoto Bio-Pharma…